EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieMultizentrische StudieOpen Access · CC BY 4.0

Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Pre-, and Postbiotics: A Multi-Country Multi-Center Prospective Randomized Controlled Study in Infants with Regurgitation

Silvia Salvatore, Viktoriia Klymenko iD, Yuliia Karpushenko iD, Maria Durczak-Hilleman, Andrii Loboda iD, Viktoriia Petrashenko, Wiesław Olechowski, Gianluca Lista iD, Fabio Meneghin iD, Sonia Amodio iD, Anke Bongers, Thomas Ludwig und 1 weitere

Nutrients · 2024

DOI: 10.3390/nu16060899 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Nutrients, 2024. Verfasst von Silvia Salvatore und 12 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Department, Hospital "F. Del Ponte", University of Insubria, 21100 Varese, Italy. Hauptthemen laut MEDLINE: Galactans, Gastrointestinal Diseases, Plant Gums. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Danone (Netherlands), Danone Nutricia Research, Utrecht, The Netherlands.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This multi-center prospective randomized controlled trial was a tolerance and safety study investigating the thickener locust bean gum (LBG) in infants with regurgitation, to support the re-evaluation of the safety of LBG in infant formula. The primary objective was to demonstrate that after an 8-week intervention, stool consistency was not inferior (i.e., was not looser or more watery) in infants fed an anti-regurgitation (AR) formula containing LBG vs. the stool consistency of infants fed with an unthickened control formula. A total of 103 full-term infants with regurgitation were randomized to the test or control formula. The test formula contained LBG (0.4 g/100 mL), short-chain galacto-oligosaccharides, and long-chain fructo-oligosaccharides (scGOS/lcFOS; 9:1; 0.4 g/100 mL) and postbiotics and the control formula contained scGOS/lcFOS (0.8 g/100 mL), the same amount of postbiotics, and did not contain LBG. The average stool consistency score at the 8th intervention week was the primary outcome parameter. Secondary outcome parameters were stool consistency at other timepoints, stool frequency, Infant Gastrointestinal Symptom Questionnaire (IGSQ) score, growth, (serious) adverse events ([S]AEs), regurgitation severity, and infant well-being. Overall, the infants were 36.9 ± 12.9 [mean ± SD] days old, 62.7% girls in the test, and 50.0% girls in the control group. The primary analysis showed that the test group did not have looser or more watery stools than the control group. IGSQ sum scores decreased comparably in both groups. The frequency of regurgitation was significantly lower in the test group compared to the control group (mixed model repeated measurement, p ≤ 0.028) and parent-reported well-being scores were favorable. Adequate growth was observed in both groups. Both products were well-tolerated and safe and the AR formula with LBG was efficacious in reducing regurgitation frequency. This study provides further evidence for the dietary management of regurgitation by LBG-containing formulae in infants who are not exclusively breastfed, and the reassurance it can bring to parents.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GalactansGastrointestinal DiseasesPlant GumsInfantFemaleHumansMaleProspective StudiesMannansVomitingFecesOligosaccharidesInfant FormulaDouble-Blind Method

Stichwörter der Autor:innen

functional gastrointestinal disordergastroesophageal refluxlocust bean gumregurgitationthickened formula

Substanzen

locust bean gumGalactansMannansOligosaccharidesPlant Gums

Autor:innen und Institutionen

  • Pediatric Department, Hospital "F. Del Ponte", University of Insubria, 21100 Varese, Italy.
  • Propaedeutics of Paediatrics No. 2, Communal Nonprofit Enterprise "City Children's Clinical Hospital # 19" of Kharkiv City Council, 61051 Kharkiv, Ukraine.
  • EPOKA Niepubliczny Zaklad Opieki Zdrowotnej Piotr Chodkiewicz Sp. z o.o., 88-400 Znin, Poland.
  • Department of Pediatrics, Sumy State University, 40000 Sumy, Ukraine.
  • Alergo-Med Specjalistyczna Przychodnia Lekarska Sp. z o.o., 33-100 Tarnow, Poland.
  • SC Neonatologia e Terapia Intensiva Neonatale, Ospedale dei Bambini "V. Buzzi", 20154 Milano, Italy.

ORCID-Profile: Viktoriia Klymenko, Yuliia Karpushenko, Andrii Loboda, Gianluca Lista, Fabio Meneghin, Sonia Amodio, Yvan Vandenplas

Förderung

  • Danone (Netherlands)
  • Danone Nutricia Research, Utrecht, The Netherlands

Zitieren

APA

Salvatore, S., Klymenko, V., Karpushenko, Y., Durczak-Hilleman, M., Loboda, A., Petrashenko, V., Olechowski, W., Lista, G., Meneghin, F., Amodio, S., Bongers, A., Ludwig, T., & Vandenplas, Y. (2024). Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Pre-, and Postbiotics: A Multi-Country Multi-Center Prospective Randomized Controlled Study in Infants with Regurgitation. Nutrients. https://doi.org/10.3390/nu16060899

Vancouver

Salvatore S, Klymenko V, Karpushenko Y, Durczak-Hilleman M, Loboda A, Petrashenko V, et al. Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Pre-, and Postbiotics: A Multi-Country Multi-Center Prospective Randomized Controlled Study in Infants with Regurgitation. Nutrients. 2024. doi:10.3390/nu16060899

BibTeX
@article{Salvatore2024,
  author = {Salvatore, Silvia and Klymenko, Viktoriia and Karpushenko, Yuliia and Durczak-Hilleman, Maria and Loboda, Andrii and Petrashenko, Viktoriia and Olechowski, Wiesław and Lista, Gianluca and Meneghin, Fabio and Amodio, Sonia and Bongers, Anke and Ludwig, Thomas and Vandenplas, Yvan},
  title = {Tolerance and Safety of an Anti-Regurgitation Formula Containing Locust Bean Gum, Pre-, and Postbiotics: A Multi-Country Multi-Center Prospective Randomized Controlled Study in Infants with Regurgitation},
  journal = {Nutrients},
  year = {2024},
  doi = {10.3390/nu16060899}
}
Kostenlos starten →